siRNA– tag –
-
Nanotechnology
SyVento Biotech and Biotechna Forge Alliance to Advance siRNA/LNP Cancer Therapeutics into Clinical Trials
SyVento Biotech Poland Overview SyVento Biotech and Biotechna have announced a strategic partnership to co-develop siRNA/LNP-based anti-cancer therapeutics, targeting solid tumors like lung and breast cancer through precise nucleic acid ... -
Nanotechnology
Novel siRNA Drug SRN001 Targeting Amphiregulin via SAMiRNA Platform Demonstrates Favorable Safety in Phase 1 Trial
PMC (PubMed Central) International Overview A Phase 1 clinical trial for SRN001, a novel siRNA drug targeting amphiregulin delivered via the SAMiRNA platform, confirmed favorable safety and pharmacokinetic profiles. Notably, subjects exp... -
New Technology
Lipid Nanoparticles (LNP) Establish Success in COVID-19 Vaccines as Cutting-Edge Technology Essential for mRNA, siRNA Delivery
Inside Therapeutics International Overview Lipid nanoparticles (LNPs) are a cutting-edge nano-drug delivery system designed to protect and efficiently deliver nucleic acids, particularly mRNA and siRNA, to target cells. Through the succe... -
New Technology
Machine Learning Accelerates Lipid Nanoparticle (LNP) Design, Dramatically Boosting Efficiency and Speed in Therapeutic Molecule Delivery
Pharmatica International Overview While lipid nanoparticles (LNPs) are crucial for protecting and safely transporting therapeutic molecules like mRNA and siRNA to target cells, their design is inherently complex. Researchers have success... -
New Technology
Gold Nanoparticles Achieve Phenotypic Reprogramming of Cancer Stem Cells via Combined Photothermal Therapy and Gene Silencing
Dove Medical Press International Overview Gold nanoparticles (AuNPs) are making significant strides in cancer stem cell (CSC) therapy by integrating physical cytotoxicity with biochemical modulation. Their high atomic number enhances loc... -
New Technology
Precision Oncology Unleashed: Tumor-Specific Promoters and Nanocarriers Drive Next-Gen Gene Therapy, LNP-Based mRNA/siRNA Therapies Paving the Way
MDPI Switzerland Overview Precision cancer gene therapy is being transformed by the integration of tumor-specific promoters and nanodelivery systems, significantly enhancing therapeutic specificity. A range of nanocarriers, including LNP... -
Nanotechnology
Precision RNA Delivery: Preclinical Research Focuses on Targeted LNP Platforms Beyond Hepatic Uptake
jobRxiv USA Overview Preclinical research in LNP-based RNA delivery is prioritizing strategies to overcome inherent liver tropism and achieve targeted delivery to specific cell populations. The goal is to develop and optimize advanced na... -
New Technology
Theranostic Lipid-Based Nanoparticles for Cancer Treatment: Integrating Diagnostics and Enhanced Drug Delivery
ACS Applied Nano Materials USA Overview This review highlights advancements in lipid-based nanoparticles (LNPs) as theranostic platforms for cancer treatment, integrating therapeutic payloads with imaging agents for real-time monitoring ... -
Nanotechnology
Advancing Cancer Therapy: siRNA Nanoparticle Delivery Strategies and Clinical Progress
MDPI Switzerland Overview This review details strategic approaches for siRNA nanoparticle delivery and outlines advancements in their clinical application for tumor therapy. Nanotechnology offers a technical pathway to boost siRNA delive... -
Nanotechnology
Translational Progress in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons
PMC (PubMed Central) International Overview This review article comprehensively examines lipid nanoparticles (LNPs) as highly adaptable nanocarrier systems for cancer therapy and diagnostics. LNPs leverage structural flexibility, biocomp...
1